Rockwell Medical climbs on product purchase agreement

Rockwell Medical

17/12/2024 11:49

** Shares of dialysis products maker Rockwell Medical
 RMTI.O  rise 16.9% to $2.35 premarket
    ** Co enters a product purchase agreement for its
hemodialysis product, SteriLyte, that is expected to generate
upwards of $10 million in net sales in 2025
    ** Says the agreement has an effective term of up to 5
years, and includes incremental price increases for the product
each subsequent year
    ** Up to last close, stock up 6.4% YTD

    

 (Reporting by Christy Santhosh)
 ((Christy.Santhosh@thomsonreuters.com))